Nicotine pouches get FDA approval

In a First-of-Its-Kind Decision, FDA Will Allow Marketing of Nicotine Pouches
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free synthetic pouches.
Zyn nicotine pouches get FDA approval
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes.
FDA Authorizes Marketing of Nicotine Pouches, a First for the Agency
The FDA authorized the marketing of 20 different Zyn nicotine pouch products -- the first brand to clear this regulatory hurdle in the increasingly popular class of single-use sachets of flavored nicotine designed to be placed between the lip and gums, which have been available for more than a decade.
US FDA grants first market authorization of nicotine pouches to Zyn
The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by the regulator for the fast-growing nicotine pouches segment in the country.
FDA authorizes marketing of Zyn nicotine pouches
The Food and Drug Administration on Thursday authorized the marketing of Zyn nicotine pouches, citing extensive scientific review. Why it matters: This is the first FDA authorization of any nicotine pouch,
FDA authorizes marketing of nicotine pouches for the first time
These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for continued growth.
FDA approves sales and marketing for Zyn nicotine pouches
Marketing for the popular nicotine pouch product, Zyn, has been approved by the U.S. Food and Drug Administration to help smokers quit cigarettes and other tobacco products.
Nicotine pouches get FDA approval, with some calling them Gen Z's favorite weight loss hack
Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and Drug Administration’s premarket tobacco product application (PMTA) pathway.
CBS News3d
What is Zyn? FDA OKs sales, but health concerns of the controversial nicotine pouches remain
Unlike smoking and vaping, Zyn is smoke- and tobacco-free — but the pouches still contain nicotine, an addictive chemical. This makes the product legal only for those 21 and above. The brand's ...
WHYY1d
FDA regulation of nicotine pouches can help prevent youth use, say Rutgers researchers
Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized ...
STAT5d
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Sales of nicotine pouches in the U.S. rose a whopping 641% in between 2019 and 2022. A 2023 report by the advocacy group Campaign for Tobacco-Free Kids warned about marketing of nicotine ...